Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnulf Ferlitsch

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Antiviral Therapy|September 14, 2010
von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4Sibylle Pramhas, Monika Homoncik, Peter Ferenci, et al.
Critical Care Medicine|September 9, 2005
Vasoconstrictor hyporeactivity can be reversed by antioxidants in patients with advanced alcoholic cirrhosis of the liver and ascitesArnulf Ferlitsch, Johannes Pleiner, Friedrich Mittermayer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2016
Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosisThomas Horvatits, Andreas Drolz, Kevin Roedl, et al.
Gut and Liver|November 15, 2018
von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular CarcinomaChristoph Schwarz, Fabian Fitschek, Martina Mittlböck, et al.
Viruses|October 26, 2021
Evolution of SARS-CoV-2 Key Mutations in Vienna Detected by Large Scale Screening ProgramJakob Thannesberger, Anna Edermayr, Alireza Karimi, et al.
Wiener Klinische Wochenschrift|June 16, 2012
Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experienceThomas Reiberger, Arnulf Ferlitsch, Berit Anna Payer, et al.
The American Journal of Gastroenterology|November 14, 2012
Sedation in screening colonoscopy: impact on quality indicators and complicationsChristina Bannert, Karoline Reinhart, Daniela Dunkler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2016
The trigger matters - outcome of hepatorenal syndrome vs. specifically triggered acute kidney injury in cirrhotic patients with ascitesTheresa Bucsics, Philipp Schwabl, Mattias Mandorfer, et al.
Atherosclerosis|July 25, 2007
Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusionJohannes Pleiner, Georg Schaller, Friedrich Mittermayer, et al.
Wiener Klinische Wochenschrift|November 27, 2016
Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosisRafael Paternostro, Doris Wagner, Thomas Reiberger, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Antiviral Therapy|September 14, 2010
von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4Sibylle Pramhas, Monika Homoncik, Peter Ferenci, et al.
Critical Care Medicine|September 9, 2005
Vasoconstrictor hyporeactivity can be reversed by antioxidants in patients with advanced alcoholic cirrhosis of the liver and ascitesArnulf Ferlitsch, Johannes Pleiner, Friedrich Mittermayer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2016
Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosisThomas Horvatits, Andreas Drolz, Kevin Roedl, et al.
Gut and Liver|November 15, 2018
von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular CarcinomaChristoph Schwarz, Fabian Fitschek, Martina Mittlböck, et al.
Viruses|October 26, 2021
Evolution of SARS-CoV-2 Key Mutations in Vienna Detected by Large Scale Screening ProgramJakob Thannesberger, Anna Edermayr, Alireza Karimi, et al.
Wiener Klinische Wochenschrift|June 16, 2012
Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experienceThomas Reiberger, Arnulf Ferlitsch, Berit Anna Payer, et al.
The American Journal of Gastroenterology|November 14, 2012
Sedation in screening colonoscopy: impact on quality indicators and complicationsChristina Bannert, Karoline Reinhart, Daniela Dunkler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2016
The trigger matters - outcome of hepatorenal syndrome vs. specifically triggered acute kidney injury in cirrhotic patients with ascitesTheresa Bucsics, Philipp Schwabl, Mattias Mandorfer, et al.
Atherosclerosis|July 25, 2007
Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusionJohannes Pleiner, Georg Schaller, Friedrich Mittermayer, et al.
Wiener Klinische Wochenschrift|November 27, 2016
Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosisRafael Paternostro, Doris Wagner, Thomas Reiberger, et al.
Pageof 10